Natera Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. We're going to go ahead and get started. I'm Tycho Peterson. It's my pleasure to introduce our next company this afternoon, Natera. (Operator Instructions)
And with that, let me turn it over to Steve.
Great. Thanks, Tycho. I'm Steve Chapman. I'm the Chief Executive Officer of Natera. Thank you for having us today.
I'm going to start off on Slide 2. So Natera is, today, the market leader in cell-free DNA technology. We've performed over 3 million tests. We are the leader in peer-reviewed published data, and we have more than 250 technology patents with over 100 issued.
We've come a long way from 2013 when we launched our first cell-free DNA test, Panorama. At that time, we were the fourth to market, and we've grown significantly since then to become the market leader. And we're glad, in 2020, we were able to expand our platform technology, the same technology that took us from fourth
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
